Why WELL Health (TSX:WELL) Stock Is Surging 17% This Week

WELL Health Technologies (TSX:WELL) stock is quickly regaining lost ground as its acquisition spree continues.

| More on:

Telehealth star WELL Health Technologies (TSX:WELL) stock is quickly regaining lost ground. Over the past six days, the stock has surged 17%. It’s now within striking distance of its all-time high of $9.84. Here’s why this stock is gaining attention again and how far this rally could stretch in the year ahead. 

WELL Health stock rebound

WELL Health stock has been tightly correlated with the tech sector and stay-at-home stocks over the past year. Over the course of 2020, the company gained 500% in market value primarily driven by the adoption of the company’s virtual healthcare and medical data services. 

However, with the pandemic receding and growth stocks collapsing, WELL Health stock took a dip too. It’s been down roughly 25% from its all-time high in February. However, there are a number of reasons why WELL Health doesn’t deserve this correlation. 

For one, healthcare technology is insulated from the economy. WELL Health’s traction and adoption are not impacted by economic growth or interest rates. Second, the stock isn’t overvalued like the rest of the tech sector. While high-flying e-commerce and electric vehicle stocks trade at double-digit multiples of annual sales, WELL Health stock is trading at a forward price-to-sales ratio of around four. 

Finally, the company’s growth is driven by acquisitions and expansion in the United States. Yesterday, WELL Health’s CEO Hamid Shahbazi announced that the team has sealed a deal to acquire MyHealth for $206 million. This deal makes WELL Health “…the largest owner-operator of outpatient medical clinics and the leading multi-disciplinary telehealth service provider in Canada,” according to Shahbazi’s tweet. 

News about this acquisition was the perfect catalyst for the stock. It’s up 15% since yesterday. WELL Health seems to have plenty of room to grow further. 

Room to grow

Currently worth about $1.6 billion, WELL Health is still a tiny challenger in a massive market. The healthcare technology sector in North America is worth hundreds of billions. Across the world, this market could be worth trillions. 

The adoption of virtual healthcare and telehealth services was spurred by the pandemic, but it’s here to here to stay now. The convenience of receiving medical attention via video calls is undeniable. Meanwhile, WELL Health is backed by heavyweight investors like Hong Kong billionaire Sir Li Ka-shing. This means it has plenty of dry powder to keep acquiring small firms like MyHealth to sustain this pace of growth. 

Before its latest acquisition, WELL health was on track to generate $300 million in annual recurring revenue. Now, the acquisition probably pushes that number higher. Assuming the stock deserves a price-to-sales ratio of eight to 10, WELL Health stock could easily double in market value by the end of the year. 

Bottom line

WELL Health stock is surging again as news of its latest acquisition is made public. The purchase of MyHealth makes the company the largest private healthcare provider in Canada. This model is also being expanded in the U.S., which means investors have plenty of growth to look forward to. 

If the team can achieve its revenue growth targets and the market can offer a more reasonable valuation ratio, the stock could double before the end of the year. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vishesh Raisinghani owns shares of WELL Health Technologies. The Motley Fool has no position in any of the stocks mentioned.

More on Tech Stocks

investment research
Tech Stocks

Is OpenText Stock a Buy, Sell, or Hold for 2025?

Is OpenText stock poised for a 2025 comeback? AI ambitions, a 3.8% yield, and cash flow power make it a…

Read more »

The virtual button with the letters AI in a circle hovering above a keyboard, about to be clicked by a cursor.
Tech Stocks

Emerging Canadian AI Companies With Big Potential

These tech stocks are paving the way to an AI-filled future, but still offer enough growth ahead for a strong…

Read more »

Young Boy with Jet Pack Dreams of Flying
Tech Stocks

Is Constellation Software Stock a Buy, Sell, or Hold for 2025?

CSU stock has long been a strong option for high growth, high value stocks. But are there now too many…

Read more »

An investor uses a tablet
Tech Stocks

Canadian Tech Stocks to Buy Now for Future Gains

Not all tech stocks are created equal. In fact, these three are valuable options every investor should consider.

Read more »

dividend growth for passive income
Tech Stocks

2 Rapidly Growing Canadian Tech Stocks With Lots More Potential

Celestica (TSX:CLS) and Constellation Software (TSX:CSU) are Canadian tech darlings worth watching in the new year.

Read more »

BCE stock
Tech Stocks

10% Yield: Is BCE Stock a Good Buy?

The yield is bigger than it's ever been in the company's history. That might not be a good thing.

Read more »

Happy shoppers look at a cellphone.
Tech Stocks

So You Own Shopify Stock: Is it Still a Good Investment?

Shopify (TSX:SHOP) stock has had a run, but there's still room to the upside.

Read more »

A person uses and AI chat bot
Tech Stocks

AI Where No One’s Looking: Seize Growth in These Canadian Stocks Before the Market Catches Up

Beyond flashy headlines about generative AI, these two Canadian AI stocks could deliver strong returns for investors who are willing…

Read more »